Early buyers will receive 10% customization on this report.
Factors such as rising aging population; significant patient population suffering from DVT, varicose veins, and lymphedema; and availability of clinical evidence favoring the adoption of compression therapy in the treatment of different diseases are driving the growth of the market.
Based on product, the compression garments segment is estimated to account for the largest share in 2017.
Based on product, the compression therapy market is segmented into compression garments, compression braces, and compression pumps. The compression garments segment is estimated to account for the largest share of the compression therapy market in 2017. The large share of this segment is attributed to the use of compression garments in a wide range of indications such as varicose veins, edema, DVT, and lymphedema.
Based on technique, the dynamic compression therapy segment is estimated to witness the highest growth during the forecast period.
On the basis of technique, the compression therapy market is segmented into static and dynamic compression therapy. The dynamic compression therapy segment is expected to grow at the highest CAGR during the forecast period.
Rising number of hip replacement surgeries globally (coupled with the increasing geriatric population and high prevalence of orthopedic diseases) and the higher incidence of target conditions such as DVT and lymphedema are the key factors driving the growth of the dynamic compression therapy segment.
Based on application, the varicose vein treatment segment is estimated to account for the largest share of the market in 2017.
On the basis of application, the compression therapy market is segmented into varicose vein treatment, deep vein thrombosis (DVT) treatment, lymphedema treatment, leg ulcer treatment, and other applications. The varicose vein treatment segment is estimated to account for the largest share of the global compression therapy market in 2017. The growing prevalence of varicose veins is the main factor driving the growth of the segment.
North America is expected to dominate the compression therapy market in 2017.
Geographically, the compression therapy market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to account for the largest share of the market in 2017. The market in North America is primarily driven by the rising number of orthopedic and spinal surgeries and the presence of a number of compression therapy product manufacturers in the region. However, Asia-Pacific is expected to register the highest growth rate during the forecast period. This high growth is attributed to the rapid expansion of target patient population in the region.
Some of the major players in the market include BSN medical (Germany), DJO Global Inc. (U.S.), medi GmbH & Co KG (Germany), Tactile Medical (U.S.), PAUL HARTMANN AG (Germany), SIGVARIS (Switzerland), Sanyleg S.r.l. (Italy), 3M Company (U.S.), ConvaTec Inc. (U.K.), ArjoHuntleigh (Getinge Group) (Sweden), and Julius Zorn GmbH (Juzo) (Germany).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
